Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors
Eugene Izumchenko(Johns Hopkins University), K. Paz(Champions Oncology (United States)), Daniel Ciznadija(Champions Oncology (United States)), Ido Sloma(Champions Oncology (United States)), Amanda Katz(Champions Oncology (United States)), David Vasquez-Dunddel(Champions Oncology (United States)), Ido Ben-Zvi(Champions Oncology (United States)), Justin Stebbing(Imperial College London), William P. McGuire(Virginia Commonwealth University), William Proctor Harris(University of Washington), Robert G. Maki(Icahn School of Medicine at Mount Sinai), Andrew Gaya, A Bedi(Johns Hopkins University), Stergios Zacharoulis(Royal Marsden Hospital), Rajani Ravi(Johns Hopkins University), Leonard H. Wexler(Memorial Sloan Kettering Cancer Center), Mohammad Obaidul Hoque(Johns Hopkins University), Carlos Rodríguez‐Galindo(Dana-Farber Cancer Institute), Harvey I. Pass(NYU Langone Health), Nir Peled(Sheba Medical Center), Angela M. Davies(Champions Oncology (United States)), Ronnie Morris(Champions Oncology (United States)), Manuel Hidalgo(Boston University), D. Sidransky(Johns Hopkins University)
Cited by 337Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis